Nasopharyngeal aspirates and stool sample collection for molecular tuberculosis testing in children with severe pneumonia - a mixed methods study

Diagnosing tuberculosis in young children has long been a stubborn hurdle for doctors. The disease, caused by a bacteria that settles in the lungs, is notoriously difficult to catch in kids under five because they cannot cough up the deep lung fluid that usually carries the evidence. Without a clear sample, doctors often have to guess, which delays treatment and allows the illness to spread. For decades, the standard way to get a sample involved waking a child in the middle of the night to collect stomach fluid, a process that is invasive, uncomfortable, and often fails to yield enough material for testing. The medical community has been searching for a gentler, more reliable way to find the bacteria without causing unnecessary distress to the child or the family.

A recent study set out to test two such alternatives: collecting mucus from the back of the nose and collecting stool. Researchers worked across six countries with high rates of tuberculosis, enrolling 542 children under five who were already hospitalized with severe pneumonia. The team, led by trained nurses, attempted to gather these samples using a method called nasopharyngeal aspiration, where a thin tube gently draws mucus from the nose, and by asking parents to provide a stool sample. They wanted to know if these methods were safe, if the children could tolerate them, and most importantly, if they could actually find the tuberculosis bacteria. The study also asked the people involved—nurses, parents, and even the older children in the group—how they felt about the procedures, looking for clues on how to make the experience better for everyone.

The results showed that these methods are possible and offer a viable path forward. Nearly every child, 99.8 percent, had a successful nose sample collected, and three-quarters of the group provided a stool sample. When the lab tested these samples using a rapid molecular test designed to spot the bacteria and check for drug resistance, it found the disease in eight children. The nose samples identified the bacteria in eight cases, while the stool samples found it in three. This suggests that the nose is a source of evidence for the disease in these young patients, offering a potential alternative to the more invasive stomach procedures.

Safety and comfort were also carefully measured. While a small number of children had a tiny bit of blood in their nose samples, and a few experienced brief changes in heart rate or mild breathing issues, these events were rare and temporary. The nurses, who assessed the discomfort on a scale from zero to ten, noted that the procedure was much more difficult to perform than it was for the children to endure. Most children showed only mild distress during the collection. When the nurses and parents were interviewed afterward, they acknowledged that the nose procedure was painful, yet they all agreed it was worth it because it aimed to improve the child's health. The parents trusted the nurses' skills and appreciated the new approach, while the nurses felt that with continued training, they could become even more confident and efficient at gathering these samples.

The study also highlighted a practical difference between the two methods. While the nurses found the nose procedure quick and less invasive than the old stomach method, they noted that collecting stool depended entirely on the child's natural timing, which could be frustrating for families waiting for a result. Despite this, the overall picture is clear: using nose mucus and stool offers a viable, child-friendly option for diagnosing tuberculosis in young children with severe pneumonia. The findings suggest that in high-risk areas, these samples can be collected safely and effectively, offering a real chance to catch the disease early without the heavy burden of older, more invasive techniques.